Patient Leaflet Updated 29-Sep-2020 | Daiichi Sankyo UK Limited
Package Leaflet: Information for the user
Motifene® 75 mg Capsules
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
What is in this leaflet:
1. What Motifene is and what it is used for
2. What you need to know before you take Motifene
3. How to take Motifene
4. Possible side effects
5. How to store Motifene
6. Contents of the pack and other information
1. WHAT MOTIFENE IS AND WHAT IT IS USED FOR
Diclofenac sodium, the active ingredient in Motifene, is one of a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs) and is used to reduce pain and inflammation. Some of the pellets inside the Motifene capsule shell release diclofenac quickly to give a rapid effect (gastro-resistant pellets). The remainder of the pellets dissolve more slowly to produce a longer lasting effect (prolonged release pellets).
Motifene can be used for the treatment of pain and inflammation due to:
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MOTIFENE
Do not take Motifene:
If you think any of these apply to you, or you are unsure, do not take the capsules. Talk to your doctor first and follow the advice given.
Warnings and precautions
Talk to your doctor or pharmacist before taking Motifene, particularly if you have any of the following health problems:
Talk to your doctor before taking Motifene if you are also taking other NSAIDs, as Motifene should not be used at the same time as other NSAIDs.
If you have any of the following health problems, you may need to take special care while taking the medicine as your condition could get worse:
Tell your doctor if you are about to have major surgery.
Because Motifene is a NSAID, it can make the symptoms of an infection (such as fever, pain) less noticeable.
Tell your doctor if you recently had or you are going to have a surgery of the stomach or intestinal tract before receiving/taking/using Motifene, as Motifene can sometimes worsen wound healing in your gut after surgery.
Medicines such as Motifene may be associated with a small increased risk of heart attack (“myocardial infarction”) or stroke. Any risk is more likely with high doses and prolonged treatment. Do not exceed the recommended dose or duration of treatment.
Side effects may be minimised by using the lowest effective dose for the shortest duration necessary.
If you are older (65 years and over), your doctor may want to monitor you carefully while you are taking Motifene.
Children and adolescents
Motifene is not recommended for children and adolescents under the age of 18.
Other medicines and Motifene
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular, tell your doctor or pharmacist about any of the following:
Taking Motifene with food and drink
Motifene is best taken with or after food.
Pregnancy and breast-feeding
Tell your doctor before taking Motifene if you are pregnant or breast-feeding. As with other non-steroidal anti-inflammatory drugs, Motifene may make it more difficult to become pregnant. You should inform your doctor if you are planning to become pregnant or if you have problems becoming pregnant.
Motifene must not be taken during the last three months of pregnancy (see “Do not take Motifene” above). It is not usually recommended at other stages of pregnancy, but you may be able to take it if your doctor advises that it is necessary for you.
Motifene should be avoided if you are breast-feeding, as small amounts of the medicine may pass into breast milk.
Driving and using machines
These capsules can cause some people to feel dizzy or giddy, drowsy or sleepy, tired or have problems with their vision. If this happens, do not drive or use machines until the symptoms wear off. Ask your doctor for advice.
3. HOW TO TAKE MOTIFENE
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is one capsule of Motifene, once or twice a day as prescribed.
It is important that the second dose is taken 8-12 hours after the first dose and that no more than two capsules of Motifene are taken in any 24 hour period.
Motifene must be swallowed whole with a drink of water (about half a glass). Do not chew or break open the capsules. The capsules are best taken with or after food. It may help you to remember to take your capsules if you take them at the same time every day, perhaps with breakfast or an evening meal.
If you take more Motifene than you should
If you take more capsules than you should or if a child accidentally swallows some, go to your doctor or nearest emergency department immediately and take your medicine pack with you.
If you forget to take Motifene
If it is a little more than 12 hours since your previous dose, take the forgotten dose and then adjust the timing of your next dose to 8-12 hours later. Do not take a double dose to make up for the forgotten dose and do not take more than two capsules in 24 hours.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can cause side effects, although not everybody gets them. Taking the lowest effective dose for the shortest possible time will minimise side effects.
Some side effects can be serious. STOP taking Motifene and tell your doctor immediately if you have any of the following symptoms:
These are the other side effects known about so far with Motifene:
Common side effects (may affect up to 1 in 10 people):
Headache, dizziness or giddiness, vertigo, sickness, feeling sick, flatulence, diarrhoea, loss of appetite, changes in blood test results, skin rashes.
Rare side effects (may affect up to 1 in 1,000 people):
Liver problems including hepatitis and jaundice (yellowing of the skin or whites of the eyes), sleepiness, rashes and spots, swelling caused by a build-up of fluid (known as ‘oedema’).
Very rare side effects (may affect up to 1 in 10,000 people):
Memory problems, pins and needles, disorientation, impaired hearing, insomnia, irritability, fits, anxiety, nightmares, tremor, mood changes, psychotic reactions, changes in taste, stiff neck, depression, confusion, hallucinations, bleeding in the brain, feeling unwell, tiredness, tinnitus (ringing in the ears), blurred vision, double vision, eye pain, constipation (including blockages), problems swallowing, hair loss, eczema, unusual bruising, kidney problems, urinary problems (e.g. any change in the usual amount or colour of the urine), severe liver problems including liver failure, sensitivity to light, flaky skin, blisters on the skin and sore mouth/eyes, inflammation of the pancreas, swelling of the tongue, high blood pressure, inflammation of the blood vessels, chest pain, palpitations, heart failure, inflammation of the lungs, changes in blood cell levels.
Medicines such as Motifene may be associated with a small increased risk of heart attack (“myocardial infarction”) or stroke.
Reporting of side effects:
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
5. HOW TO STORE MOTIFENE
Keep this medicine out of the sight and reach of children.
Motifene should not be stored above 25°C.
Do not use this medicine after the expiry date printed on the box and on the blister strip. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. CONTENTS OF THE PACK AND OTHER INFORMATION
What Motifene contains
The active substance is diclofenac sodium.
Each hard gelatin capsule contains 75 mg diclofenac sodium.
The other ingredients are:
Microcrystalline cellulose, Povidone K25, colloidal anhydrous silica, methacrylic acid ethyl acrylate copolymer, propylene glycol, talc.
Microcrystalline cellulose, Povidone K25, colloidal anhydrous silica, ammonio methacrylate copolymer A and B, triethyl citrate, talc.
Indigocarmine (E132), titanium dioxide (E171), gelatin.
Gelatin, ink (containing shellac, propylene glycol, titanium dioxide (E171)).
What Motifene looks like and contents of the pack
Motifene are blue and clear capsules and are marked ‘D 75 M’.
The capsules are available in packs of 2, 4, 28 and 56.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
This leaflet was last revised in September 2020
Problems reading this leaflet?
To listen to or request a copy of this leaflet in Braille, large print or audio, please call, free of charge 0800 198 5000 (UK only)
Please be ready to give the following information:
Product name: Motifene 75 mg Capsules
Reference Number: PL 08265/0003
This is a service provided by the Royal National Institute of Blind People.
1st Floor, Building 4, Uxbridge Business Park, Sanderson Road, Uxbridge, UB8 1DH, UK
+44 (0) 800 028 5122
+44 (0) 800 028 5122
+44 (0) 800 028 5122
+44 (0) 800 028 5122